Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

BurstDR Spinal Cord Stimulation Versus Sham in Established Responders

NCT: NCT07779733 · NOT_YET_RECRUITING

NCT IDNCT07779733
StatusNOT_YET_RECRUITING
Start Date2026-09-30
Completion2027-03-31
SponsorUmeå University (OTHER)
First posted
Last updated

Brief Summary

This study aims to determine whether ongoing BurstDR spinal cord stimulation (SCS) provides pain relief beyond sham stimulation in patients with chronic pain who are established responders to BurstDR therapy. Participants already implanted with an SCS system and experiencing stable clinical benefit from BurstDR will undergo both active stimulation and sham stimulation in a randomized, double-blind crossover design. Each participant will therefore serve as their own control. The primary question is whether pain intensity is lower during active BurstDR stimulation compared with sham stimulation. The study will also evaluate treatment satisfaction, patient-reported changes in sleep, mood, daily activity and social activity, the effectiveness of blinding, and short-term safety and tolerability.

Frequently Asked Questions

What is BurstDR Spinal Cord Stimulation Versus Sham in Established Responders?

BurstDR Spinal Cord Stimulation Versus Sham in Established Responders is a clinical trial registered under NCT07779733. Current status: NOT_YET_RECRUITING.

What is the status of NCT07779733?

The current status of NCT07779733 (BurstDR Spinal Cord Stimulation Versus Sham in Established Responders) is: NOT_YET_RECRUITING.

When did BurstDR Spinal Cord Stimulation Versus Sham in Established Responders start?

BurstDR Spinal Cord Stimulation Versus Sham in Established Responders started on 2026-09-30.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.